Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study

著录项

• 来源
  《Rheumatology》 |2016年第10期|共9页
• 作者

  Joensuu Jaana T.; Aaltonen Kalle J.; Aronen Pasi; Sokka Tuulikki; Puolakka Kari; Tuompo Riitta; Korpela Markku; Vasala Mikko; Ilva Kirsti; Nordstrom Dan; Blom Marja;

  展开▼
• 作者单位

  Univ Helsinki Fac Pharm FIN-00014 Helsinki Finland;

  Univ Helsinki Fac Pharm FIN-00014 Helsinki Finland;

  Univ Helsinki Fac Pharm FIN-00014 Helsinki Finland;

  Jyvaskyla Cent Hosp Dept Rheumatol Jyvaskyla Finland;

  South Karelia Cent Hosp Dept Med Lappeenranta Finland;

  Univ Helsinki Cent Hosp Dept Med FIN-00014 Helsinki Finland;

  Tampere Univ Hosp Ctr Rheumat Dis Tampere Finland;

  Kainuu Cent Hosp Dept Internal Med Kajaani Finland;

  Kanta Hame Cent Hosp Dept Med Hameenlinna Finland;

  Univ Helsinki Cent Hosp Dept Med FIN-00014 Helsinki Finland;

  Univ Helsinki Fac Pharm FIN-00014 Helsinki Finland;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 免疫性疾病;
• 关键词

  cost-effectiveness; rheumatoid arthritis; biological DMARDs; observational study;

  机译：成本效益;类风湿性关节炎;生物DMARDS;观察研究;